Max Healthcare Institute Limited has informed the Exchange about Investor Presentation
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare has filed its investor presentation ahead of four conferences in September 2025 (Motilal, CITIC CLSA, Jefferies, J.P. Morgan). The company is positioned as India's largest hospital chain by market cap at ₹1.2 lakh crore, operating ~5,200 beds across 22 facilities with ~76% occupancy and ~26% ROCE in Q1 FY26. A detailed capacity expansion roadmap reveals plans to add 8,200+ potential beds, with ~4,700 beds expected in the next 3-4 years at an estimated capex outflow of ₹6,434 crore. Q1 FY26 results showed 27% YoY revenue growth to ₹2,460 crore, though operating EBITDA margin contracted to 24.9% from 25.8% YoY on higher direct costs from newer units. Net debt stood at ₹1,755 crore with strong operating cash generation of ₹389 crore in the quarter. The presentation also details growth in Max Lab (39% CAGR) and Max@Home (22% CAGR) adjacencies.
The presentation provides investors with a clear long-term growth blueprint through capacity expansion and asset-light models, supporting the bull case on the stock. However, the YoY margin contraction in Q1 FY26 due to integration costs at new units is a near-term watchpoint. Increased institutional engagement across four major investor conferences could improve trading liquidity and price discovery.